DIRECT-SAFE: A Randomized Controlled Trial of DIRECT Endovascular Clot Retrieval versus Standard Bridging Therapy

다국어 초록 (Multilingual Abstract)

Background and Purpose The benefit regarding co-treatment with intravenous (IV) thrombolysis before mechanical thrombectomy in acute ischemic stroke with large vessel occlusion remains unclear. To test the hypothesis that clinical outcome of ischemic stroke patients with intracranial internal carotid artery, middle cerebral artery or basilar artery occlusion treated with direct endovascular thrombectomy within 4.5 hours will be non-inferior compared with that of standard bridging IV thrombolysis followed by endovascular thrombectomy.
Methods To randomize 780 patients 1:1 to direct thrombectomy or bridging IV thrombolysis with thrombectomy. An international-multicenter prospective randomized open label blinded endpoint trial (PROBE) (ClincalTrials.gov identifier: NCT03494920).
Results Primary endpoint is functional independence defined as modified Rankin Scale (mRS) 0–2 or return to baseline at 90 days. Secondary end points include ordinal mRS analysis, good angiographic reperfusion (modified Thrombolysis in Cerebral Infarction score [mTICI] 2b–3), safety endpoints include symptomatic intracerebral hemorrhage and death.
Conclusions DIRECT-SAFE will provide unique information regarding the impact of direct thrombectomy in patients with large vessel occlusion, including patients with basilar artery occlusion, with comparison across different ethnic groups.

참고문헌 (Reference)

1 Gilgen MD, "Younger stroke patients with large pretreatment diffusion-weighted imaging lesions may benefit from endovascular treatment" 46 : 2510-2516, 2015

2 Ma H, "Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke" 380 : 1795-1803, 2019

3 Altman DG, "The revised CONSORT statement for reporting randomized trials : explanation and elaboration" 134 : 663-694, 2001

4 Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke" 372 : 2285-2295, 2015

5 Fischer U, "Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke (SWIFT DIRECT)" 2021

6 Anderson CS, "Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke" 374 : 2313-2323, 2016

7 Bhatia R, "Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke : real-world experience and a call for action" 41 : 2254-2258, 2010

8 McArthur KS, "Improving the efficiency of stroke trials : feasibility and efficacy of group adjudication of functional end points" 44 : 3422-3428, 2013

9 Wang W, "Hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke: mechanisms, models, and biomarkers" 52 : 1572-1579, 2015

10 Lin CH, "Endovascular thrombectomy without versus with intravenous thrombolysis in acute ischemic stroke : a non-inferiority meta-analysis of randomized clinical trials" 2021

11 Yang P, "Endovascular thrombectomy with or without intravenous alteplase in acute stroke" 382 : 1981-1993, 2020

12 Goyal M, "Endovascular thrombectomy after large-vessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials" 387 : 1723-1731, 2016

13 Campbell BC, "Endovascular therapy for ischemic stroke with perfusion-imaging selection" 372 : 1009-1018, 2015

14 Emberson J, "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials" 384 : 1929-1935, 2014

15 Suzuki K, "Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke : the SKIP randomized clinical trial" 325 : 244-253, 2021

16 Zi W, "Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke : the DEVT randomized clinical trial" 325 : 234-243, 2021

17 Roos Y, "Direct endovascular treatment (dEVT) versus intravenous alteplase followed by endovascular treatment in patients with acute stroke due to a large vessel occlusion" 2021

18 Coutinho JM, "Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke : a pooled analysis of the SWIFT and STAR studies" 74 : 268-274, 2017

19 Churilov L, "An improved method for simple, assumption-free ordinal analysis of the modified Rankin Scale using generalized odds ratios" 9 : 999-1005, 2014

20 Mehta CR, "Adaptive increase in sample size when interim results are promising : a practical guide with examples" 30 : 3267-3284, 2011

21 Howard G, "A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes" 43 : 664-669, 2012

22 Suzuki Y, "A review of the mechanisms of blood-brain barrier permeability by tissue-type plasminogen activator treatment for cerebral ischemia" 10 : 2-, 2016

23 Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke" 372 : 11-20, 2015